← Back
Medtronic
MDT · listed on the New York Stock Exchange · worth $123.49 billion
$96.54
−0.59% on Oct 30
No insider bought Medtronic stock in the last year. They sold it 16 times, $14.34 million in all. Five members of Congress reported trading Medtronic in the last year.
Red dot = an insider sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
1.3B shares
100% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, five insiders sold Medtronic stock and none bought. Three of the 16 sales are marked on the filing as planned in advance; all by company executives. The biggest seller was Harry Skip Kiil, EVP & President Cardiovascular.
Planned sales
Form 144 notices filed for Medtronic in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
Michael Marinaro filed to sell 10,420 shares on 15 Oct; sold 10,420 by 15 Oct10b5-1 plan adopted 17 Mar 2026 · Notice on SEC.gov
CEO Geoffrey Martha filed to sell 50,000 shares on 15 Oct; sold 50,000 by 15 Oct10b5-1 plan adopted 16 Jul 2026 · Notice on SEC.gov
President Harry Skip Kiil filed to sell 1,483 shares on 16 Sep; sold 1,483 by 16 SepNotice on SEC.gov
US Congress
Members of Congress who reported trading Medtronic in the last year. They have up to 45 days to report, so the newest trades show up late.
MemberTradeAmountWhose accountTradedReported
All reports
Every insider trade and SEC report we hold for Medtronic.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Oct 16SoldMichael MarinaroOct 16 · Traded Oct 15 · EVP, Pres MedSurg and Americas · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.10,420 @ $96.00$1M
Oct 16SoldGeoffrey MarthaOct 16 · Traded Oct 15 · Chairman and CEO · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.50,000 @ $95.00$4.75M
Sep 17SoldHarry Skip KiilSep 17 · Traded Sep 16 · EVP & President Cardiovascular1,483 @ $93.65$138.9K
Jul 9SoldMatthew R. WalterJul 9 · Traded Jul 8 · SVP, Chief HR Officer · A trade scheduled ahead of time under a written plan, so its timing was set before the day it happened.3,102 @ $83.15$257.9K
15 more with Pro →Analysts, earnings and news
Analysts' price target
$98.00 average
26 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
4 of 4 quarters above
Q2 '26$1.55 a share+$0.01
Q1 '26$1.36 a share+$0.02
Q4 '25$1.36 a share+$0.05
Q3 '25$1.26 a share+$0.03